Blastic Plasmacytoid Dendritic Cell Neoplasia

1 clinical trials · Condition

Record	Firm	Date
First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) (NCT05086315)	Sanofi	2021-12-08

Every clearance here is in the API, with alerts when new ones post.